pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4690 |
Genomic Coordinates | chr11: 65636310 - 65636369 |
Description | Homo sapiens miR-4690 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4690-5p | |||||||||||||||||||||||||||
Sequence | 1| GAGCAGGCGAGGCUGGGCUGAA |22 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | DCTN4 | ||||||||||||||||||||
Synonyms | DYN4, P62 | ||||||||||||||||||||
Description | dynactin subunit 4 | ||||||||||||||||||||
Transcript | NM_001135643 | ||||||||||||||||||||
Other Transcripts | NM_001135644 , NM_016221 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on DCTN4 | |||||||||||||||||||||
3'UTR of DCTN4 (miRNA target sites are highlighted) |
>DCTN4|NM_001135643|3'UTR 1 AAGGTTCCACTGGAGGGCAGATCCCAAAGGACAGTATCACCGTAAACCTGCGTTAAAATGTGGAAGCTGCTGCTTCATTA 81 GGCCTTGTTTATAACGATGTACCCATGCACTACGGAATTCTATTGCTAAGAAAGTGGGAGCATAGGCAAGGCATTGGGAA 161 CACAGGGTAGCTGCTGTTGCTCTTGCTCTCACCCCTGTTGACACCAGTAAGTCTGTGTCTCCCTCACTGAACCCTGCACG 241 TTGAGTAACAGCAGCATAATTCCATCCTAGGAAAGGGGATGGGTGTTCCTTGGAATGGCATTGTATTTACCACCTGAGAA 321 ACTCTGTACTGTCTCTTGATCTGATCTCACTAAGGATCACAATGTCACAGATGAAACTTAAATGATAACCCAAAGGTAGA 401 CCTGCTGTTAATGATCCAGCATTGGTCACAATGTACCAACTGCTTTCTGCATTCCGTTAAATATCATCTAACAGTCTAAA 481 ACATATCCCTTCATTGCCATAATGGCTGCCATTTTGCCATAGATTTCCATATAACTGAAAAACTGAATTGTCACTTTATC 561 TTTAGTATCATGATGATTGGAAAAACCTGTGAAGTTGTTAAGGCACTCTCATTTGCCCTCTTTTTCTAAGTGAATACAGG 641 ACACGTATTAGTTGTTCTTAATTTTTTTCCCAGTAAAATATGGATCTTTTAAGAAGAATTTGAGAAGCAAACAATTACAT 721 GTCATGTCAAGGGGGTAGCAGATTCCATTCGTTTTCAATATTGCCACAATACCCAGGGATTAATGCTGCCACAGGGGGGC 801 AATCTTTATTTGTCTTACTTCCTACCCCTTCCCTGTTCTGCCTCTTTAACTCAGTTAAGTTGTTCTGTTTGGGACCTGGA 881 AAAGAACCCAAAGAAAACCTGAGTGGACAGGTTCATTTCTGGAATGCAGAAAACATTTTAAAGGCTAGATTTTTAGAATA 961 TTCTCAACTAGCATTCTTTCCATTGATTTGAAGGGGAAATTAACTATTATAATCTCTTGAATCCAAAACTGGATATTAAG 1041 AACTTTCCCCCTTACTAAGTTTAAGACTTTTGTCATGTGGTGAGTCAAATAAGACCATTTTGATTGTAAACCATAAAATA 1121 GTTCAGCAAGTAGCCCACAGTTCTGGCCTAACAGCAGACTTGCTGTTTTCACTTGGTATCCTGGAGTTGGGTTGCTAACC 1201 TTAATTTCTATGATGTTTTCTAAAATGAAACTTGATAAAGTAGACCACCAGCTGCACCGTGTTTTCTGTAAAAGTATTGT 1281 TAGTAAGTGGCCAAGAGACTTGAGGAAAATACAGATTTTTTGTTTACCTTGGTCTTGTTTTAAGTCTTAAAAAATTAAAG 1361 ATAACATTATAATGTAGAATACAGATGGGACATAGTCCTTGTAAGCTTCCCTTGAAAATGTTTTAAATATTTAGGAAGCT 1441 TTTAAAAGACACTAAATTGTACTCTAAAAGACACTAAATTGTACTAATTGTACAAAGGTCAAGCCAATTTTATGAAACAG 1521 TCCTACAGAGTAATATATGTGATGCAGTGTAAGAAGGAAAATACTCATCTCTAACATTATGGTAATAACATTTAGCCTCT 1601 TAGGAGTTGGAGCAGGGGGATGGGTAATTACAGATTTGCAGACTATAGAAAGAGTTTCATTTTTTTGTGACCCCACAGAG 1681 TCTCAAATTTTTATTTCACTACCTGCTAGAGCCTACTGTGAAATCACTGCTCCATATTTGCCAGTGGAGGAAATGGGCAT 1761 AGAGTAGAGAATAGCTTCATATGTTTACACGTTTGCATAGACTACACACATGTCATGCGTTTATGGCAGGTAGCTGGTAT 1841 TTATTCCCCAAAGTAATAATGTTGAAGTATGGGTCTCATCATTCCCATACACAGAAACACAAAACACTTTGATCATAAAC 1921 TTTTTTCTTCAGAAGCCAAACTAACTTGCAGAATAATAGAGCCACTGGTTTAATGTTTCCTCAAGATAGGTTTTAGTGTA 2001 AGCTAGTATTCTGTGTGTTCGTAGAAATGATTCAATACCTGCAGCTGGTGAATTAGGAATTGTATTTGTTGCCTTTTTTA 2081 TATTAGATGAGGTGCAAAAATTTTAATGCTAGTCAGTATGCACCACCACAGGAAAGTTAGATCCCATTAGCACTTGAAAC 2161 TACAGCTTTGGAAACTTAGGCTAAGTTAATTTGGATTTGTTACTTGATTCACCTACTGACCTTTTCTTTTGTTTGAAGTG 2241 CTTATCAGCATAATGAGCTAAGTGTCATGCATATTTGTGAAGAAACACCCTTTTTGGTCCCTTTTGGGACAGAGAGGTAC 2321 TCCTTGATCTTTATGAATGACAGGTTACTGTTTTGCCTTATTGCTTAACTTAATGTAGTGAAATAAAGCAGACAAAGCTT 2401 GAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_001135644 | 3UTR | UACCUGCUAGAGCCUACUGUGAAAUCACUGCUCCAUAUUUGCCAGUGGAGGAAAUGGGCAUAGAGUAGAGAAUAGCUUCAUAUGUUUACACGUUUGCAUAGACUACACACAUGUCAUGCGUUUAUGGCAGGUAGCUGGUAUUUAUUCCCCAAAGUAAUAAUGUUGAAGUAUGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_001135644 | 3UTR | AGAGCCUACUGUGAAAUCACUGCUCCAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_001135644 | 3UTR | CCUGCUAGAGCCUACUGUGAAAUCACUGCUCCAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_001135644 | 3UTR | CACUACCUGCUAGAGCCUACUGUGAAAUCACUGCUCCAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_001135644 | 3UTR | CUGCUAGAGCCUACUGUGAAAUCACUGCUCCAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_001135644 | 3UTR | CUACCUGCUAGAGCCUACUGUGAAAUCACUGCUCCAUAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000447998.2 | 3UTR | UCUCAAAUUUUUAUUUCACUACCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
42 hsa-miR-4690-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT071223 | FCF1 | FCF1, rRNA-processing protein | 2 | 2 | ||||||||
MIRT082025 | COX6B1 | cytochrome c oxidase subunit 6B1 | 2 | 4 | ||||||||
MIRT144286 | NFAT5 | nuclear factor of activated T-cells 5 | 2 | 2 | ||||||||
MIRT202048 | ZSWIM1 | zinc finger SWIM-type containing 1 | 2 | 2 | ||||||||
MIRT213227 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT445866 | ENTPD7 | ectonucleoside triphosphate diphosphohydrolase 7 | 2 | 2 | ||||||||
MIRT455955 | CYP4A22 | cytochrome P450 family 4 subfamily A member 22 | 2 | 2 | ||||||||
MIRT459110 | CYP4A11 | cytochrome P450 family 4 subfamily A member 11 | 2 | 2 | ||||||||
MIRT460327 | SH3RF1 | SH3 domain containing ring finger 1 | 2 | 2 | ||||||||
MIRT461645 | ZSWIM4 | zinc finger SWIM-type containing 4 | 2 | 2 | ||||||||
MIRT463497 | ZC3H10 | zinc finger CCCH-type containing 10 | 2 | 2 | ||||||||
MIRT464900 | UBALD1 | UBA like domain containing 1 | 2 | 2 | ||||||||
MIRT472262 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT478028 | DNAJC8 | DnaJ heat shock protein family (Hsp40) member C8 | 2 | 2 | ||||||||
MIRT483753 | ALDH9A1 | aldehyde dehydrogenase 9 family member A1 | 2 | 2 | ||||||||
MIRT485186 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 4 | ||||||||
MIRT486550 | DCTN4 | dynactin subunit 4 | 2 | 2 | ||||||||
MIRT495087 | IGSF3 | immunoglobulin superfamily member 3 | 2 | 2 | ||||||||
MIRT495141 | ZNRF1 | zinc and ring finger 1 | 2 | 2 | ||||||||
MIRT501269 | NHS | NHS actin remodeling regulator | 2 | 4 | ||||||||
MIRT503264 | KIF18B | kinesin family member 18B | 2 | 2 | ||||||||
MIRT507165 | GAS2L3 | growth arrest specific 2 like 3 | 2 | 2 | ||||||||
MIRT512519 | BTBD19 | BTB domain containing 19 | 2 | 2 | ||||||||
MIRT528862 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT546526 | SERTAD3 | SERTA domain containing 3 | 2 | 2 | ||||||||
MIRT555058 | PYURF | PIGY upstream reading frame | 2 | 2 | ||||||||
MIRT574028 | RIMBP3C | RIMS binding protein 3C | 2 | 2 | ||||||||
MIRT574106 | VASN | vasorin | 2 | 2 | ||||||||
MIRT630923 | UNC93A | unc-93 homolog A | 2 | 2 | ||||||||
MIRT640178 | AGO1 | argonaute 1, RISC catalytic component | 2 | 2 | ||||||||
MIRT655959 | NDST1 | N-deacetylase and N-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT659747 | CCDC30 | coiled-coil domain containing 30 | 2 | 2 | ||||||||
MIRT666062 | STK40 | serine/threonine kinase 40 | 2 | 2 | ||||||||
MIRT670696 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 4 | ||||||||
MIRT674196 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT686948 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT697466 | ZC3H4 | zinc finger CCCH-type containing 4 | 2 | 2 | ||||||||
MIRT698221 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT699448 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT718999 | UTP15 | UTP15, small subunit processome component | 2 | 2 | ||||||||
MIRT720024 | TFAP2C | transcription factor AP-2 gamma | 2 | 2 | ||||||||
MIRT721530 | DKK3 | dickkopf WNT signaling pathway inhibitor 3 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|